What is the ticker symbol for Opthea Limited?

Opthea Limited trades under the ticker OPT on NASDAQ.

What sector does Opthea Limited operate in?

Opthea Limited is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OPT in a portfolio?

PortView shows OPT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Opthea Limited (OPT) Stock Analysis

NASDAQHealthcareBiotechnology

$3.41+1.49%

1-year price historyRange $1.86 – $5.92

52-week range$3.41

$1.79$6.30

What Opthea Limited does

Opthea Limited is an Australian biopharmaceutical company operating at the clinical development stage, focused on discovering and commercializing treatments primarily for ophthalmic conditions. Its research and development efforts are underpinned by an intellectual property portfolio that covers Vascular Endothelial Growth Factors (VEGF) C and D, along with VEGF Receptor-3. This proprietary foundation targets diseases stemming from abnormal blood and lymphatic vessel growth or vascular leakage. The company's primary therapeutic candidate, OPT 302, is a soluble form of VEGFR-3 currently undergoing clinical evaluation. This novel agent is being developed for treating wet neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME). Furthermore, OPT 302 is designated as a pioneering VEGF C/D inhibitor, designed for administration alongside VEGF A inhibitors to manage wet neovascular AMD and other retinal diseases. Founded in 1984, the company officially changed its name from Circadian Technologies Limited to Opthea Limited in December 2015. Its corporate headquarters are located in South Yarra, Australia.

Key metrics

Market cap

$4.24B

P/E (TTM)

-1.52

EPS (TTM)

$-2.25

Beta

1.67

50-day avg

$4.37

200-day avg

$3.53

52-week high

$6.30

52-week low

$1.79

CEO

Jeremy Max Levin Ba Zoology, Dphil, Mb Bchir,

ETFs linked to OPT

Broad-market and Healthcare sector ETFs an investor holding Opthea Limited is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how OPT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OPT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Opthea Limited?: Opthea Limited trades under the ticker OPT on NASDAQ.
Which exchange is OPT listed on?: OPT is listed on NASDAQ.
What sector does Opthea Limited operate in?: Opthea Limited is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OPT in a portfolio?: PortView shows OPT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.